NetworkNewsBreaks Archive - Page 1959 of 2081

ThursdayAug 03, 2017 12:12 pm

NetworkNewsBreaks – SeeThruEquity Updates Coverage on Earth Science Tech, Inc. (ETST)

SeeThruEquity has updated its coverage and issued a price target of $4.12 on shares of Earth Science Tech, Inc.’s (OTC: ETST) stock. Among other highlights, the analyst noted the company’s new joint venture with Varsity Group, LLC to use its patented Kanna-Blend formula to develop CBD-based e-liquids to be sold under ETST's subsidiary, KannaBidoid Inc. The company has already finalized four product labels for it e-liquids that will start selling by the end of August 2017. Additionally, ETST has inked an agreement with Absolu Communications to handle the branding and rollout of the company’s much-anticipated MSN-2 medical device. For more…

ThursdayAug 03, 2017 12:08 pm

NetworkNewsBreaks – CHF Solutions, Inc. (NASDAQ: CHFS) Starts Aquadex FlexFlow® System Manufacturing Transition to its Minnesota Facility; Shares Rise

CHF Solutions, Inc. (NASDAQ: CHFS) shares surged 14% after the company this morning said it has commenced the process of transitioning the manufacturing of the Aquadex FlexFlow System from an indirect subsidiary of Baxter International, Inc. (NYSE: BAX) to CHF Solutions’ facility in Eden Prairie, Minnesota. Last week, the company completed the transfer of the manufacturing assets that it acquired from Baxter as part of the Aquadex acquisition that was completed on August 5, 2016. The company expects to begin manufacturing its Aquadex FlexFlow system products in the fourth quarter of 2017. “Bringing the manufacturing of the Aquadex FlexFlow system…

ThursdayAug 03, 2017 12:05 pm

NetworkNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Selects Bioscience SA as Polish CRO

Shares of Moleculin Biotech (NASDAQ: MBRX) rose 7% this morning on news that the company has selected Bioscience SA, a Polish contract research organization (CRO), to begin identifying and preparing clinical testing sites in Poland for Annamycin. The company’s drug candidate, Annamycin, is being evaluated for the treatment of relapsed or refractory acute myeloid leukemia (AML). "One of the biggest challenges for most clinical trials is recruiting the right patients on a timely basis. We believe adding Polish sites to our planned trial introduces a significant population of qualified patients, and selecting Bioscience helps ensure we reach those patients effectively…

ThursdayAug 03, 2017 12:00 pm

NetworkNewsBreaks – Micronet Enertec Technologies, Inc. (NASDAQ: MICT) Receives Largest Purchase Order Since 2012; Shares Higher

Micronet Enertec Technologies (NASDAQ: MICT) shares surged 34% this morning after the company said its Mobile Resource Management (MRM) subsidiary Micronet Ltd., via its wholly owned subsidiary Micronet Inc., has received purchase orders valued at approximately $4.3 million for its recently released TREQr5 product. The orders for the ruggedized telematics Android on-board computer were received by a fleet management solutions provider that is a current customer. The purchase order marks the largest order received for the company since 2012 and brings the company’s backlog to a record amount of $13.5 million. "The magnitude of these orders, and the fact that…

ThursdayAug 03, 2017 9:08 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Management Quoted in “HIGH TIMES” Article

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the publication of “Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work” on August 1, 2017, by Javier Hasse on the website of “HIGH TIMES,” a publication that’s served as the preeminent source for cannabis information since 1974. In the article, both Ram Mukunda, CEO of IGC, and Dr. Chuanhai Cao, the company’s key advisor, were quoted with respect to the potential therapeutic effects of THC on Alzheimer’s disease, which is noted as America’s most expensive ailment.…

WednesdayAug 02, 2017 3:23 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Spotlighted by Technical420

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, including cannabinoids, was recently spotlighted in an article on Technical420.com. The publication highlighted, in detail, several of the company’s key developments and growth catalysts. “During the last few months, Lexaria has improved its fundamental story through the following developments: 1) The company applied for a new patent from the U.S., 2) Lexaria has advanced its agreements and launched new businesses, 3) Expands its Reach into Asia, 4) Focused on R&D with major organizations, and 5) The company’s cash position has…

WednesdayAug 02, 2017 11:40 am

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on August 2, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: RWLK 11.53% – News: Study shows soft suit exoskeleton improves walking ability for stroke patients GLUU 4.30% – News: COO and CFO will present at 2017 Canaccord Growth Conference on August 10 CLSN 4.14% – News: Issues translational data from OVATION Study in newly diagnosed patients with advanced ovarian cancer CTIC 3.79% – News: Completes enrollment of PIX306 trial of PIXUVRI for aggressive B-cell non-Hodgkin lymphoma MVIS 3.36% – News: Has shipped first development…

WednesdayAug 02, 2017 11:22 am

NetworkNewsBreaks – ReWalk Robotics (NASDAQ: RWLK) Shares Higher on Publication of Restore™ System Enhancing Walking Ability for Stroke Survivors

Shares of ReWalk Robotics (NASDAQ: RWLK) are up 15% this morning after the company’s Restore™ System was utilized in a study published in the Journal of Science Translational Medicine. The study found that use of a soft suit exoskeleton system enabled normal walking ability for ambulatory patients following a stroke. The prototype utilized in the study was created by the Wyss Institute and is now moving toward commercialization by ReWalk Robotics. "The ongoing research at the Wyss Institute on soft exosuits adds a new dimension to exoskeletons that can potentially meet the needs of individuals that have had a stroke,…

WednesdayAug 02, 2017 11:18 am

NetworkNewsBreaks – Celsion Corporation (NASDAQ: CLSN) Trading Higher following Positive Translational Data from OVATION Study

Celsion (NASDAQ: CLSN) this morning reported “convincing evidence” of gene transfer and immune system activity from its OVATION Study combining the company’s GEN-1 gene-mediated immunotherapy with the standard of care for newly diagnosed patients with advanced ovarian cancer. “These translational research findings demonstrate that GEN-1 in ovarian cancer patients is biologically active and creates a shift in the tumor microenvironment in the peritoneal cavity in a dose-dependent manner and promotes a pro-immune T-cell population dynamic in the tumor microenvironment,” Dr. Khursheed Anwer, Celsion’s executive vice president and chief science officer, stated in the press release. “These distinct immunological changes in…

WednesdayAug 02, 2017 10:22 am

NetworkNewsBreaks – Dow Clinches New Record, Surpassing 22,000 with Boost from Apple (NASDAQ: AAPL)

The Dow Jones Industrial Average this morning rocketed past the 22,000 mark, clipping a new milestone with a boost from Apple, Inc. (NASDAQ: AAPL). Shares of the tech giant are up 5.7% at a new 52-week high of $158.67 in morning trade. The Dow earlier this year crossed the 20,000 mark for the first time in its 120-year history and currently moves in a 52-week range of 17,883.56-22,036.10. For more on the Dow’s record performance, visit: http://nnw.fm/M1Skp More from NetworkNewsBreaks ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) Announces Close of $15 Million Investment from Cannabis Wheaton EyeGate Pharmaceuticals, Inc. (NASDAQ:…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks